ZIPEXOLE pramipexole dihydrochloride 0.5 mg tablets blister pack

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

pramipexole dihydrochloride monohydrate, Quantity: 0.5 mg

Tilgængelig fra:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

pramipexole dihydrochloride monohydrate

Lægemiddelform:

Tablet, uncoated

Sammensætning:

Excipient Ingredients: silicon dioxide; povidone; pregelatinised maize starch; magnesium stearate; mannitol

Indgivelsesvej:

Oral

Enheder i pakken:

10, 30, 100

Recept type:

(S4) Prescription Only Medicine

Terapeutiske indikationer:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.,-the symptomatic treatment of primary Restless Legs Syndrome.

Produkt oversigt:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '4' debossed on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorisation status:

Licence status A

Autorisation dato:

2014-09-23